Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study
Sebastiano Cicco, Angelo Vacca(University of Bari Aldo Moro), Flavio Scarilli(University of Bari Aldo Moro), Gianfranco Lauletta(University of Bari Aldo Moro), Roberto Ria(University of Bari Aldo Moro), Carmen Palumbo(University of Salerno), Claudia Morelli(University of Bari Aldo Moro), Fabrizio Pappagallo(University of Bari Aldo Moro), Davide Fiore Bavaro(Humanitas University), Lucia Diella(Humanitas University), Antonio Giovanni Solimando(University of Parma), Antonio Fusillo(University of Bari Aldo Moro), Elisabetta Sturdà(University of Bari Aldo Moro), Federica Albanese(University of Bari Aldo Moro), Annalisa Saracino(University of Bari Aldo Moro), Marialuisa Sveva Marozzi(University of Bari Aldo Moro)
Cited by 1
Related Papers
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival
|Journal of Clinical Oncology|2014|210
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165